As India prepares for Budget 2026, the pharmaceutical sector seeks to transition from production to innovation, advocating for increased public healthcare investment and diversified exports to boost ...

In the evolving landscape of private markets, direct lending has emerged as a resilient and attractive strategy for investors seeking yield and diversification. Even as asset yields have moderated ...

Amid escalating geopolitical tensions between China and Japan, China has recently imposed stricter review measures on rare earth exports to Japan. Chinese authorities now reportedly require exporters ...

BLACKSHEARS, GA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — REMSleep Holdings, Inc. (OTCQB: RMSL), developer of the FDA-cleared DeltaWave™ CPAP mask ...

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. The market is pricing Strategy (NASDAQ: MSTR), formerly ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk plans to ...

Bitcoiners wanting to focus on short-term factors should be “fairly methodical and mathematical,” says Strategy CEO Phong Le. Bitcoin’s market fundamentals have stayed strong in 2025, despite the ...

As the global automotive industry remains focused on tariff barriers and policy battles, Chinese automakers have quietly advanced their overseas strategies into a new phase, aiming for massive export ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...

The stock market endured some midday turbulence, but closed solidly higher in the wake of the November consumer price index. The Dow Jones Industrial Average rose 67 points, or 0.1%. The S&P 500 was ...

Rivian is reiterated as a Buy, driven by the improving manufacturing leverage, the compelling valuations, and the healthy balance sheet bridging its future operating leverage. The upcoming Autonomy+ ...